Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McCabe

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Journal of the Neurological Sciences|August 28, 2022
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic strokeS T Lim, S J X Murphy, S M Murphy, et al.
European Heart Journal|May 14, 2009
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trialAlan D Michelson, Andrew L Frelinger, Eugene Braunwald, et al.
Journal of Neurology|May 1, 2014
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic strokeW O Tobin, J A Kinsella, G F Kavanagh, et al.
Journal of the American College of Cardiology|July 10, 2002
Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trialDavid A Morrow, Elliott M Antman, Assaad Sayah, et al.
Journal of Neurology|October 16, 2012
Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic strokeW O Tobin, J A Kinsella, G F Kavanagh, et al.
American Heart Journal|April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyGad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
Journal of the American College of Cardiology|June 20, 2006
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trialC Michael Gibson, David A Morrow, Sabina A Murphy, et al.
Circulation|February 11, 2004
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudyStephen D Wiviott, Christopher P Cannon, David A Morrow, et al.
Journal of the Neurological Sciences|July 18, 2024
von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapyD R Smith, S T Lim, S J X Murphy, et al.
Stroke|September 25, 2019
Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting StudyMandy D Müller, John Gregson, Dominick J H McCabe, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Journal of the Neurological Sciences|August 28, 2022
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic strokeS T Lim, S J X Murphy, S M Murphy, et al.
European Heart Journal|May 14, 2009
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trialAlan D Michelson, Andrew L Frelinger, Eugene Braunwald, et al.
Journal of Neurology|May 1, 2014
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic strokeW O Tobin, J A Kinsella, G F Kavanagh, et al.
Journal of the American College of Cardiology|July 10, 2002
Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trialDavid A Morrow, Elliott M Antman, Assaad Sayah, et al.
Journal of Neurology|October 16, 2012
Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic strokeW O Tobin, J A Kinsella, G F Kavanagh, et al.
American Heart Journal|April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyGad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
Journal of the American College of Cardiology|June 20, 2006
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trialC Michael Gibson, David A Morrow, Sabina A Murphy, et al.
Circulation|February 11, 2004
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudyStephen D Wiviott, Christopher P Cannon, David A Morrow, et al.
Journal of the Neurological Sciences|July 18, 2024
von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapyD R Smith, S T Lim, S J X Murphy, et al.
Stroke|September 25, 2019
Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting StudyMandy D Müller, John Gregson, Dominick J H McCabe, et al.
Pageof 26